HTAtlas
← Back to explore

Hungarian Methodological Guidelines for Economic Evaluation of Healthcare Interventions

Guidelinepeer-reviewed

These guidelines provide the official standards for conducting economic evaluations of healthcare interventions in Hungary, especially for reimbursement decisions. They define how studies should be designed and reported to support health technology assessment.

At a glance

Use when

Conducting economic evaluations for HTA and reimbursement applications in Hungary

Avoid when

Applying in non-Hungarian contexts where different methodological standards prevail

Inputs

Healthcare intervention data, cost data, outcome measures (e.g. QALYs), epidemiological parameters

Outputs

Economic evaluation report compliant with Hungarian reference-case standards, including incremental cost-effectiveness ratios (ICERs)

How it works

Foundational methodological framework established by the Hungarian HTA community and published in the European Journal of Health Economics (Gulacsi et al., 2002). Specifies reference-case requirements for pharmacoeconomic evaluations submitted for HTA and reimbursement purposes in Hungary, including study perspective, time horizon, discounting, and analytical methods.

HTA domains
Clinical Effectiveness, Costs & Economic Evaluation, Organisational aspects
Assumptions
A reference-case perspective is required for reimbursement submissions; willingness-to-pay thresholds apply; long-term outcomes may be modeled
Strengths
Provides standardized, nationally accepted criteria for HTA submissions in Hungary; enhances transparency and comparability of economic evaluations
Limitations
May not incorporate latest international methodological advances since foundational (2002); limited flexibility for novel study designs

Questions this answers

References & sources

Similar by meaning

Beta record. Based on the original catalogue summary; primary-source enrichment pending.